当前位置: 首页 > 详情页

Bispectral index monitoring prevent awareness during total intravenous anesthesia: a prospective, randomized, double-blinded, multi-center controlled trial

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C ◇ 中华系列

机构: [1]Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing 100020, Peoples R China [2]Subei Peoples Hosp Jiangsu Prov, Dept Anesthesiol, Yangzhou 225001, Jiangsu, Peoples R China [3]Mil Gen Hosp Beijing Peoples Liberat Army, Dept Anesthesiol, Beijing 100700, Peoples R China [4]Capital Med Univ, Beijing Tongren Hosp, Dept Anesthesiol, Beijing 100730, Peoples R China [5]Capital Med Univ, Xuanwu Hosp, Dept Anesthesiol, Beijing 100053, Peoples R China [6]Peking Univ, Hosp 3, Dept Anesthesiol, Beijing 100193, Peoples R China [7]Jilin Univ, Hosp 1, Dept Anesthesiol, Changchun 130021, Jilin, Peoples R China [8]Guangzhou First Municipal Peoples Hosp, Dept Anesthesiol, Guangzhou 510180, Guangdong, Peoples R China [9]So Med Univ, Nanfang Hosp, Dept Anesthesiol, Guangzhou 510515, Guangdong, Peoples R China [10]Ningbo Univ, Coll Med, Lihuili Hosp, Dept Anesthesiol, Ningbo 315041, Zhejiang, Peoples R China [11]Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Anesthesiol, Shanghai 200092, Peoples R China [12]Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Anesthesiol, Xian 710004, Shaanxi, Peoples R China [13]Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Anesthesiol, Xian 710004, Shaanxi, Peoples R China [14]China Med Univ, Hosp 1, Dept Anesthesiol, Shenyang 110001, Liaoning, Peoples R China
出处:
ISSN:

关键词: awareness complications general anesthesia monitoring bispectral index

摘要:
Background Awareness is a serious complication of general anesthesia. In China, the incidence of intraoperative awareness was 1% in patients undergoing total intravenous anesthesia (TIVA). In this study, we compared the incidence of awareness between Bispectral index (BIS)-guided and routine TIVA protocol and evaluated the effect of BIS on preventing awareness. Methods A prospective, randomized, double-blinded, multicenter controlled trial was performed. Patients (>= 18 years of age) undergoing TIVA were randomly divided into BIS-guided group (Group A, BIS was monitored and recommended to maintain between 40-60) and control group (Group B, BIS was monitored but the screen was covered). The intraoperative BIS values were downloaded and the BIS trends of confirmed awareness cases were analyzed to determine whether light anesthesia existed. Results Of the total 5228 patients, 2919 patients were assigned to Group A and 2309 to Group B. Four cases of confirmed awareness (0.14%) were reported in the BIS-guided group and 15 (0.65%) in the control group (P=0.002, OR=0.21, 95% confidence intervals: 0.07-0.63). The incidence of possible awareness (0.14% vs. 0.26%, P=0.485) and dreaming (3.1% vs. 3.1%, P=0.986) was comparable between BIS-guided group and the control group. Among the 19 confirmed awareness cases, intraoperative BIS trends of six cases were downloaded and identified. Five of them showed signs of light anesthesia as BIS >60 and lasted 19-106 minutes, whereas one case had a stable BIS trend and the values were within 60 during the operation. Another five awareness cases were reviewed for anesthesia procedures, of which improper light anesthesia were confirmed. Conclusions BIS-guided TIVA (BIS was recommended to maintain between 40-60) decreased the risk of awareness compared with routine TIVA. The main reason for awareness was light anesthesia. Chin Med J 2011;124(22):3664-3669

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2010]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
JCR分区:
出版当年[2009]版:
Q3 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2009版] 出版当年五年平均 出版前一年[2008版] 出版后一年[2010版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing 100020, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院